share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰製藥 | 4：持股變動聲明-高管 Bozic Carmen
美股SEC公告 ·  06/28 16:09
Moomoo AI 已提取核心訊息
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 26, 2024. The transaction was executed at a price of $471.72 per share, resulting in a total sale value of $1,075,521.60. Following the sale, Bozic's direct holdings in the company amount to 30,099 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 26, 2024. The transaction was executed at a price of $471.72 per share, resulting in a total sale value of $1,075,521.60. Following the sale, Bozic's direct holdings in the company amount to 30,099 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
2024年6月26日，Vertex Pharmaceuticals Inc.(VRTX)的執行副總裁兼首席營銷官Carmen Bozic出售了2280股普通股。成交價爲471.72美元/股，總交易金額爲1,075,521.60美元。出售後，Bozic在該公司的直接持股爲30,099股普通股。該交易是通過公開市場交易進行的，正如該公司最新的提交文件所述。
2024年6月26日，Vertex Pharmaceuticals Inc.(VRTX)的執行副總裁兼首席營銷官Carmen Bozic出售了2280股普通股。成交價爲471.72美元/股，總交易金額爲1,075,521.60美元。出售後，Bozic在該公司的直接持股爲30,099股普通股。該交易是通過公開市場交易進行的，正如該公司最新的提交文件所述。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息